People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Biotechnology, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AZTherapies, INC | — | Biotechnology | Series B | $85.8M | $549.3M | 2020 |
| Applied Minerals, Inc. | — | Mining & Resources | Series A | $19.5M | $4.0M | 2017 |
| Iquum Inc | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2010 |
David Taft at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Taft on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Keith Greenfield | 2 | 3 |
| John Levy | 1 | 10 |
| Noah Gottdiener | 1 | 4 |
| Una Ryan | 1 | 4 |
| Robert S. Warren | 1 | 3 |
| David R Elmaleh | 1 | 3 |
| Ali Zamani | 1 | 3 |
| Peter S. Conti | 1 | 3 |
| Keith S. Greenfield | 1 | 2 |
| David Elmaleh | 1 | 2 |
| Christopher Carney | 1 | 2 |
| Morris D Weiss | 1 | 2 |
| Brian Bartlett | 1 | 2 |
| Peter Conti | 1 | 2 |
| John R Porter | 1 | 2 |
| Thierry Porte | 1 | 2 |
| Gillian Sandler | 1 | 2 |
| John S. Porter | 1 | 1 |
| Ronald R Tompkins | 1 | 1 |
| David S. Taft | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.